Clinical Trials · NCT01368588

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Active Not RecruitingPhase 3Gonadorelin (Investigational)
Phase
Phase 3
Recruitment status
Active Not Recruiting
Sponsor
Radiation Therapy Oncology Group
Enrollment
2,590
Start date
Jul 2011
Locations
478 sites, 6 countries
Primary endpoint
Percentage of Participants Alive (Overall Survival)
View Gonadorelin compound reference